Andreas Halvorsen's ROIV Position Overview
Andreas Halvorsen (via Viking Global Investors Lp) currently holds 6.44 M shares of Roivant Sciences Ltd. (ROIV) worth $139.82 M, representing 0.37% of the portfolio. First purchased in 2021-Q4, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Andreas Halvorsen has maintained a strategic position in ROIV, demonstrating sustained confidence in this investment. Largest reduction occurred in Q4 2025, reducing 17.15 M shares.
Analysis based on 13F filings available since 2013 Q2
Andreas Halvorsen's Roivant Sciences (ROIV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Roivant Sciences (ROIV) Trades by Andreas Halvorsen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -17.15 M | Reduce 72.69% | 6.44 M | $21.70 |
| Q3 2025 | -10.64 M | Reduce 31.09% | 23.59 M | $15.13 |
| Q2 2025 | -11.78 M | Reduce 25.59% | 34.24 M | $11.27 |
| Q1 2025 | -1.8 M | Reduce 3.76% | 46.01 M | $10.09 |
| Q4 2024 | -6.29 M | Reduce 11.63% | 47.81 M | $11.83 |
| Q3 2024 | -15.06 M | Reduce 21.77% | 54.1 M | $11.54 |
| Q2 2024 | -213,115 | Reduce 0.31% | 69.16 M | $10.57 |
| Q4 2023 | -4.07 M | Reduce 5.54% | 69.37 M | $11.23 |
| Q3 2023 | -1.8 M | Reduce 2.40% | 73.43 M | $11.68 |
| Q2 2023 | -13 M | Reduce 14.73% | 75.24 M | $10.08 |
| Q4 2021 | +88.24 M | New Buy | 88.24 M | $10.08 |
Andreas Halvorsen's Roivant Sciences Investment FAQs
Andreas Halvorsen first purchased Roivant Sciences Ltd. (ROIV) in Q4 2021, acquiring 88,238,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Andreas Halvorsen has held Roivant Sciences Ltd. (ROIV) for 17 quarters since Q4 2021.
Andreas Halvorsen's largest addition to Roivant Sciences Ltd. (ROIV) was in Q4 2021, adding 88,238,700 shares worth $889.45 M.
According to the latest 13F filing for Q4 2025, Andreas Halvorsen's firm, Viking Global Investors Lp, owns 6,443,191 shares of Roivant Sciences Ltd. (ROIV), valued at approximately $139.82 M.
As of the Q4 2025 filing, Roivant Sciences Ltd. (ROIV) represents approximately 0.37% of Andreas Halvorsen's publicly disclosed stock portfolio, making it one of their key holdings.
Andreas Halvorsen's peak holding in Roivant Sciences Ltd. (ROIV) was 88,238,700 shares, as reported at the end of Q4 2021.